Maximus, Inc. (MMS) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. lifted its stake in Maximus, Inc. (NYSE:MMS) by 3.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 278,352 shares of the health services provider’s stock after purchasing an additional 10,418 shares during the period. Principal Financial Group Inc. owned 0.43% of Maximus worth $17,433,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Neuburgh Advisers LLC lifted its position in shares of Maximus by 1.9% in the 1st quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock worth $105,000 after purchasing an additional 32 shares during the period. Glen Harbor Capital Management LLC lifted its position in shares of Maximus by 1.9% in the 1st quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock worth $145,000 after purchasing an additional 44 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Maximus by 10.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock worth $148,000 after purchasing an additional 220 shares during the period. First Bank & Trust lifted its position in shares of Maximus by 4.2% in the 2nd quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock worth $157,000 after purchasing an additional 101 shares during the period. Finally, Elkfork Partners LLC lifted its position in shares of Maximus by 1.9% in the 1st quarter. Elkfork Partners LLC now owns 2,968 shares of the health services provider’s stock worth $185,000 after purchasing an additional 56 shares during the period. 97.23% of the stock is owned by hedge funds and other institutional investors.
Maximus, Inc. (MMS) opened at 63.58 on Friday. The company’s 50-day moving average is $60.72 and its 200-day moving average is $61.45. The stock has a market capitalization of $4.12 billion, a PE ratio of 20.38 and a beta of 1.37. Maximus, Inc. has a 12 month low of $43.69 and a 12 month high of $64.97.
Maximus (NYSE:MMS) last issued its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The company had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same period in the prior year, the business earned $0.79 EPS. The firm’s quarterly revenue was down 2.7% on a year-over-year basis. Equities research analysts forecast that Maximus, Inc. will post $3.13 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th were issued a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend was Friday, August 11th. Maximus’s payout ratio is 5.73%.
Several equities research analysts have recently commented on MMS shares. KeyCorp reaffirmed a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. Robert W. Baird started coverage on shares of Maximus in a research report on Sunday, September 3rd. They issued a “neutral” rating for the company. Zacks Investment Research cut shares of Maximus from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. BidaskClub cut shares of Maximus from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 6th. Finally, Maxim Group set a $66.00 target price on shares of Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company. Maximus presently has an average rating of “Hold” and an average target price of $62.43.
In other Maximus news, President Bruce Caswell sold 8,000 shares of the stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $62.21, for a total transaction of $497,680.00. Following the transaction, the president now directly owns 35,904 shares in the company, valued at approximately $2,233,587.84. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel David Francis sold 2,000 shares of the stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $58.89, for a total transaction of $117,780.00. Following the transaction, the general counsel now owns 13,716 shares in the company, valued at $807,735.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 125,403 shares of company stock worth $7,645,251. 3.10% of the stock is owned by company insiders.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.